You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 44 No. 11, November 1987 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Spectrum of Inclusion Body Myositis

Steven P. Ringel, MD; Catherine E. Kenny, MD; Hans E. Neville, MD; Ralph Giorno, MD; Michael R. Carry, PhD

Arch Neurol. 1987;44(11):1154-1157.


Abstract

• The clinical, laboratory, and biopsy features are described for a large group of patients with inclusion body myositis (IBM) (15 men and four women; mean age, 63 years). A quantitative histopathologic analysis of muscle biopsy specimens revealed less fiber necrosis and endomysial and perivascular inflammation in IBM than in polymyositis (PM) and dermatomyositis, but a more frequent occurrence of dark-angular and hypertrophied fibers. Rimmed vacuoles were present in 3.4% of all fibers and 15- to 18-nm filaments were identified in the biopsy specimens of nine of 11 patients. A panel of monoclonal antibodies immunoreactive with lymphocytes and cells of monocyte/macrophage lineage suggested that the inflammatory reaction in IBM was similar to that in PM (but not dermatomyositis) and mediated by cellular immune responses. These studies confirm the clinical and histopathologic distinctions between IBM and chronic PM, and that differentiation between these disorders is often difficult.



Author Affiliations

From the Departments of Neurology (Drs Ringel, Kenny, Neville, and Carry) and Pathology (Dr Giorno), University of Colorado Health Sciences Center, Denver.


Footnotes

Accepted for publication May 20, 1987.

Reprint requests to the Department of Neurology, University of Colorado Health Sciences Center, Campus Box B 185, 4200 E Ninth Ave, Denver, CO 80262 (Dr Ringel).



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Sporadic inclusion body myositis: Phenotypic variability and influence of HLA-DR3 in a cohort of 57 Australian cases
Needham et al.
J. Neurol. Neurosurg. Psychiatry 2008;79:1056-1060.
ABSTRACT | FULL TEXT  

Management of Dysphagia in Inclusion Body Myositis
Darrow et al.
Arch Otolaryngol Head Neck Surg 1992;118:313-317.
ABSTRACT  

Amyloid Filaments in Inclusion Body Myositis: Novel Findings Provide Insight Into Nature of Filaments
Mendell et al.
Arch Neurol 1991;48:1229-1234.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1987 American Medical Association. All Rights Reserved.